Health Technology Assessment
Analisi multidimensionale del farmaco trastuzumab (SC) in pazienti con carcinoma mammario HER2+ nel setting extraospedaliero (domiciliare) versus ospedaliero
Year2021
Year2021
Year2020
Year2022
Year2022
Year2023
Year2024
Year2024
Year2018
Year2022
Year2022
Year2020
Year2019